Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Gastric cancer (GC) is a malignant tumor that originates from the epithelium of the gastric mucosa. The latest global cancer statistics show that GC ranks fifth in incidence and fourth in mortality among all cancers, posing a serious threat to public health. While early-stage GC is primarily treated...
Main Authors: | Jiahua Liu, Qihang Yuan, Hui Guo, Hewen Guan, Zhijun Hong, Dong Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332224001914 |
Similar Items
-
Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
by: Adrian Silaghi, et al.
Published: (2023-10-01) -
Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01) -
Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives
by: Nadja Niclauss, et al.
Published: (2021-11-01) -
Gastric cancer treatment: recent progress and future perspectives
by: Wen-Long Guan, et al.
Published: (2023-05-01) -
Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
by: Xiao Bai, et al.
Published: (2023-01-01)